A new review of the evidence shows that the 21-day rule isn't a rule after all.
A groundbreaking antipsychotic, a powerful new antibiotic, and a vaccine-like prophylactic for HIV are some of the most important drugs to have arrived this year.
New data collected by the FDA has found that montelukast can bind to brain cells, which may explain the risk of mental health adverse effects linked to its use.
